Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk

Plain-language summary

This observational study evaluates the course of breast cancer cases in men and the risk of disease relapse. Male patients diagnosed with primary invasive breast carcinoma between 2000 and 2019 and followed at the participating centers were included. This was a phase-not-applicable study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Spanish Breast Cancer Research Group

Start date

9/14/2018

Estimated completion

2/24/2025

Countries

Spain

Related genes

Locations

• Ferrol, Spain
• Alcoy, Spain
• Granollers, Spain
• L'Hospitalet de Llobregat, Spain
• Sabadell, Spain
• Terrassa, Spain
• Bilbao, Spain
• Castellon, Spain
• Alcázar de San Juan, Spain
• Donostia / San Sebastian, Spain
• Donostia / San Sebastian, Spain
• Fuenlabrada, Spain
• Getafe, Spain
• Leganés, Spain
• Móstoles, Spain
• Pozuelo de Alarcón, Spain
• El Palmar, Spain
• Pamplona, Spain
• Vigo, Spain
• Avilés, Spain
• Tortosa, Spain
• A Coruña, Spain
• Barcelona, Spain
• Barcelona, Spain
• Barcelona, Spain
• Barcelona, Spain
• Cuenca, Spain
• Girona, Spain
• Granada, Spain
• Huelva, Spain
• Jaén, Spain
• Las Palmas de Gran Canaria, Spain
• Lugo, Spain
• Madrid, Spain
• Madrid, Spain
• Madrid, Spain
• Madrid, Spain
• Madrid, Spain
• Madrid, Spain
• Málaga, Spain

+14

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Male patients diagnosed with primary invasive breast carcinoma between the years 2000-2019, and who have been treated and/or followed up in the Medical Oncology Departments of participating sites.
* The enrollment of patients who died is allowed.

Exclusion Criteria:

* Male patients who do not wish to participate in the study for any reason.